Chemogenetic ON and OFF switches for RNA virus replication
Open Access
- 1 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-11
- https://doi.org/10.1038/s41467-021-21630-5
Abstract
Therapeutic application of RNA viruses as oncolytic agents or gene vectors requires a tight control of virus activity if toxicity is a concern. Here we present a regulator switch for RNA viruses using a conditional protease approach, in which the function of at least one viral protein essential for transcription and replication is linked to autocatalytical, exogenous human immunodeficiency virus (HIV) protease activity. Virus activity can be en- or disabled by various HIV protease inhibitors. Incorporating the HIV protease dimer in the genome of vesicular stomatitis virus (VSV) into the open reading frame of either the P- or L-protein resulted in an ON switch. Here, virus activity depends on co-application of protease inhibitor in a dose-dependent manner. Conversely, an N-terminal VSV polymerase tag with the HIV protease dimer constitutes an OFF switch, as application of protease inhibitor stops virus activity. This technology may also be applicable to other potentially therapeutic RNA viruses. Therapeutic application of RNA viruses requires tight control over viral activity. Here the authors design a regulatory switch that enables control over activity with clinically approved HIV protease inhibitors.This publication has 62 references indexed in Scilit:
- Inclusion Bodies Are a Site of Ebolavirus ReplicationJournal of Virology, 2012
- Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapyJournal of Molecular Medicine, 2012
- Identification of Genetically Modified Maraba Virus as an Oncolytic RhabdovirusMolecular Therapy, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Features and development of CootActa crystallographica. Section D, Structural biology, 2010
- Viral vectors: from virology to transgene expressionBritish Journal of Pharmacology, 2009
- Association of Saquinavir Plasma Concentrations with Side Effects but Not with Antiretroviral Outcome in Patients Infected with Protease Inhibitor-Susceptible Human Immunodeficiency Virus Type 1Antimicrobial Agents and Chemotherapy, 2007
- Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesVirology, 2007
- Visualization of Intracellular Transport of Vesicular Stomatitis Virus Nucleocapsids in Living CellsJournal of Virology, 2006
- UCSF Chimera?A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004